LINC02686

Across TCGA pan-cancer cohorts, LINC02686 RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated LINC02686 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher LINC02686 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC02686 expression acts as an unfavorable survival marker.

STAD, KIRC, and ESCA are the cancer types where LINC02686 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	All	0.466	0.674	.002	81	view →
KIRC	DFS	Tertile	IV	0.160	0.624	.003	36	view →
ESCA	OS	Tertile	All	0.198	0.872	.003	36	view →
CESC	DFS	Tertile	All	0.176	0.740	.005	36	view →
BLCA	DFS	Tertile	All	0.159	0.625	.016	27	view →
LGG	OS	Tertile	All	0.392	0.803	.001	21	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

LINC02686–STAD (DFS)

Open the STAD breakdown →